Intra-lateral septal infusions of folic acid alone or combined with various antidepressant drugs produce antidepressant-like actions in male Wistar rats forced to swim

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 36, Issue 1, 2012, Pages 78-84

  Molina Hernández, Miguel ^a   Téllez Alcántara, N Patricia ^a   Olivera López, Jorge I ^b,c   Jaramillo, M Teresa ^b  

^a UNIVERSIDAD VERACRUZANA   (Mexico)

^b UNIVERSIDAD AUTÓNOMA METROPOLITANA   (Mexico)

^c DEPARTAMENTO DE SISTEMAS BIOLÓGICOS   (Mexico)

Author keywords

Antidepressant; Folic acid; Forced swimming test; Lateral septal nuclei

Indexed keywords

ANTIDEPRESSANT AGENT; DESIPRAMINE; FLUOXETINE; FOLIC ACID; KETANSERIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANTIDEPRESSANT ACTIVITY; ARTICLE; CLIMBING; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; DRUG ANTAGONISM; DRUG DOSE COMPARISON; DRUG INFUSION; DRUG MECHANISM; FORCED SWIMMING TEST; IMMOBILIZATION; INTRALATERAL SEPTAL DRUG ADMINISTRATION; LIMBIC SYSTEM; MALE; MONOTHERAPY; NONHUMAN; OPEN FIELD TEST; RAT; SEROTONINERGIC SYSTEM; SWIMMING;

ANIMALS; ANTIDEPRESSIVE AGENTS; DEPRESSION; DRUG THERAPY, COMBINATION; FOLIC ACID; INFUSIONS, INTRAVENTRICULAR; MALE; RATS; RATS, WISTAR; SEPTUM OF BRAIN; SWIMMING;

EID: 82555164913     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2011.08.020     Document Type: Article

References (56)

1. Abou-Saleh M., Coppen A. Folic acid and the treatment of depression. J Psychosom Res 2006, 61:285-287.
2. Alpert J., Mischoulon D., Rubenstein G., Bottonari K., Nierenberg A., Fava M. Folinic acid (Leucovorin) as an adjunctive treatment for SSRI-refractory depression. Ann Clin Psychiatry 2002, 14:33-38.
3. Borsini F., Meli A. Is the forced swimming test a suitable model for revealing antidepressant activity?. Psychopharmacology 1988, 94:147-160.
4. Brocardo P., Budni J., Kaster M., Santos A., Rodrigues A.L. Folic acid administration produces an antidepressant-like effect in mice: evidence for the involvement of the serotonergic and noradrenergic systems. Neuropharmacology 2008, 54:464-473a.
5. Brocardo P., Budni J., Ribas K., Pinto M., Rodrigues A.L. Antidepressant-like effect of folic acid: Involvement of NMDA receptors and l-arginine-nitric oxide-cyclic guanosine monophosphate pathway. Eur J Pharmacol 2008, 598:37-42b.
6. Brotto L., Barr A., Gorzalka B. Sex differences in forced-swim and open-field test behaviours after chronic administration of melatonin. Eur J Pharmacol 2000, 402:87-93.
7. Calandreau L., Jaffard R., Desmedt A. Dissociated roles for the lateral and medial septum in elemental and contextual fear conditioning. Learn Mem 2007, 14:422-429.
8. Cervo L., Grignaschi G., Samanin R. 8-Hydroxy-2-(di-n-propylamino) tetralin, a selective serotonin-1A receptor agonist, reduces the immobility of rats in the forced swimming test by acting on the nucleus raphe dorsalis. Eur J Pharmacol 1988, 158:53-59.
9. Cho Y.J., Han J.Y., Choi J.S., Ahn H.K., Ryu H.M., Kim M.Y., Yang J.H., Nava A.A., Koren G. Prenatal multivitamins containing folic acid do not decrease prevalence of depression among pregnant women. J Obstet Gynaecol 2008, 28:482-484.
10. Contreras C.M., Marván M.L., Alcalá V., Guzmán M.A. Chronic clomipramine increase firing rate in lateral septum nuclei of the rat. Physiol Behav 1990, 48:551-554.
11. Contreras C.M., Marván M.L., Ramírez A., Muñoz A. Clomipramine enhances the excitatory actions of dorsal raphe nucleus stimulation in lateral septal neurons in the rat. Neuropsychobiology 1993, 27:86-90.
12. Contreras C.M., Molina M., Savedra M., Martínez-Mota L. Lateral septal neuronal firing rate increases during proestrus-estrus in the rat. Physiol Behav 2000, 68:279-284.
13. Contreras C.M., Chacon L., Rodríguez F., Bernal B., Gutierrez A., Savedra M. Spontaneous firing rate of lateral septal neurons decreases after forced swimming test in Wistar rat. Prog Neuropsychopharmacol Biol Psychiatry 2004, 28:343-348.
14. Coppen A., Bailey J. Enhancement of the antidepressant action of fluoxetine by folic acid: a randomized, placebo controlled study. J Affect Disord 2000, 60:121-130.
15. Crawley J.N. Exploratory behavior models of anxiety in mice. Neurosci Biobehav 1985, 9:37-44.
16. Cunha M., Machado D., Bettio L.E., Capra J.C., Rodrigues A.L. Interaction of zinc with antidepressants in the tail suspension test. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:1913-1920.
17. D'Anci K.E., Rosenberg I.H. Folate and brain function in the elderly. Curr Opin Clin Nutr Metab Care 2004, 7:659-664.
18. Delini-Stula A., Mikkelsen H., Angst J. Therapeutic efficacy of antidepressants in agitated anxious depression - a metaanalysis of moclobemide studies. J Affect Disord 1995, 35:21-30.
19. Detke M.J., Lucki I. Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: the effects of water depth. Behav Brain Res 1996, 73:43-46.
20. Detke M.J., Rickels M., Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology 1995, 121:66-72.
21. Dinopoulos A., Dori I., Parnavelas J.G. Serotoninergic innervation of the mature and developing lateral septum of the rat: a light and electron microscopic immunocytochemical analysis. Neuroscience 1993, 55:209-222.
22. Dodd S., Horgan D., Malhi G., Berk M. To combine or not to combine? A literature review of antidepressant combination therapy. J Affect Disord 2005, 89:1-11.
23. Fava M. Augmenting antidepressants with folate: a clinical perspective. J Clin Psychiatry 2007, 10:4-7.
24. Gall C., Moore R.Y. Distribution of enkephalin, substance P, tyrosine hydroxylase and 5-hydroxytryptamine immunoreactivity in the septal region of the rat. J Comp Neurol 1984, 225:212-227.
25. Gavioli E.C., Duarte F., Bressan E., Ferrara P., Coimbra R., Monteiro De Lima T.C. Antidepressant-like effect of Ro5-4864, a peripheral-type benzodiazepine receptor ligand, in forced swimming test. Eur J Pharmacol 2003, 471:21-26.
26. Gilbody S., Lightfoot T., Sheldon T. Is low folate a risk factor for depression? A meta-analysis and exploration of heterogeneity. J Epidemiol Community Health 2007, 61:631-637.
27. Givens B., Sarter M. Modulation of cognitive processes by trans-synaptic activation of the basal forebrain. Behav Brain Res 1997, 84:1-22.
28. Gutiérrez A., Contreras C.M., Mendoza R., García O., Cruz J.S. Urine from stressed rats increases immobility in receptor rats forced to swim: Role of 2-heptanone. Physiol Behav 2007, 91:166-172.
29. Harkin A., Kelly J.P., McNamara M., Connor T.J., Dredge K., Redmond A., Leonard B.E. Activity and onset of action of reboxetine and effect of combination with sertraline in an animal model of depression. Eur J Pharmacol 1999, 364:123-132.
30. Kikuchi T., Uchida H., Suzuki T., Watanabe K., Kashima H. Patients' attitudes toward side effects of antidepressants: an Internet survey. Eur Arch Psychiatry Clin Neurosci 2011, 261:103-109.
31. Korte S.M. Corticosteroids in relation to fear, anxiety and psychopathology. Neurosci Biobehav Rev 2001, 25:117-142.
32. López-Rubalcava C., Lucki I. Strain differences in the behavioral effects of antidepressant drugs in the rat forced swimming test. Neuropsychopharmacology 2000, 22:191-199.
33. Marván M.L., Guzmán M.A., Barradas J.A., Contreras C.M. Septal neurons related with hippocampus increase their firing rate after long-term clomipramine. Bol Estud Méd Biol Méx 1992, 40:15-20.
34. Micheau J., Van Marrewijk B. Stimulation of 5-HT1A receptors by systemic or medial septum injection induces anxiogenic-like effects and facilitates acquisition of a spatial discrimination task in mice. Prog Neuropsychopharmacol Biol Psychiatry 1999, 23:1113-1133.
35. Molina M., Telléz-Alcántara N.P. Estrus variation in anticonflict effects of midazolam microinjected into septal nuclei in female Wistar rats. Pharmacol Biochem Behav 2001, 68:531-537.
36. Molina M., Diaz J.L., Savedra M., Ortiz M., Contreras C.M. Raphe-septal neurons changes in sensitivity to desipramine following an early septal lesion in the rat. Prog Neuropsychopharmacol Biol Psychiatry 1996, 20:1427-1434.
37. Molina M., Tellez-Alcántara N.P., Peréz-García J., Olivera-López J.I., Jaramillo T. Synergistic interaction between ketoconazole and several antidepressant drugs with allopregnanolone treatments in ovariectomized Wistar rats forced to swim. Prog Neuropsychopharmacol Biol Psychiatry 2004, 28:1337-1345.
38. Molina M., Tellez-Alcántara N.P., Pérez-García J.P., Olivera-Lopez J.I., Jaramillo M.T. Antidepressant-like and anxiolytic-like actions of the mGlu5 receptor antagonist MTEP, microinjected into lateral septal nuclei of male Wistar rats. Prog Neuropsychopharmacol Biol Psychiatry 2006, 30:1129-1135.
39. Molina M., Tellez-Alcántara N.P., Pérez-García J., Olivera-Lopez J.I., Jaramillo-Jaimes T. Antidepressant-like actions of minocycline combined with several glutamate antagonists. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:380-386.
40. Molina M., Téllez-Alcántara N.P., Olivera-Lopez J.I., Jaramillo M.T. Antidepressant-like or anxiolytic-like actions of topiramate alone or co-administered with intra-lateral septal infusions of neuropeptide Y in male Wistar rats. Peptides 2010, 31:1184-1189.
41. Molina M., Téllez-Alcántara N.P., Olivera-López J.I., Jaramillo M.T. The folic acid combined with 17-β estradiol produces antidepressant-like actions in ovariectomized rats forced to swim. Prog Neuropsychopharmacol Biol Psychiatry 2011, 35:60-66.
42. Molina M., Téllez-Alcántara N.P., Olivera-Lopez J.I., Jaramillo T. Olanzapine plus 17-β estradiol produce antidepressant-like actions in rats forced to swim. Pharmacol Biochem Behav 2009, 93:491-497.
43. National Institutes of Health Guide for the care and use of laboratory animals Washington 1996, National Academy Press, DC.
44. Papakostas G., Petersen T., Lebowitz B., Mischoulon D., Ryan J., Nierenberg A., Bottiglieri T., Alpert J., Rosenbaum J., Fava M. The relationship between serum folate, vitamin B12, and homocysteine levels in major depressive disorder and the timing of improvement with fluoxetine. Int J Neuropsychopharmacol 2005, 8:1-6.
45. Paul R., McDonnell A., Kelly C. Folic acid: neurochemistry, metabolism and relationship to depression. Hum Psychopharmacol Clin Exp 2004, 19:477-488.
46. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1982, Academic Press, New York.
47. Pazos A., Palacios J.M. Quantitative autoradiographic mapping of serotonin receptors in rat brain. I. Serotonin-1 receptors. Brain Res 1985, 346:205-230.
48. Porsolt R.D., LePichon M., Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 1977, 266:730-732.
49. Resler G., Lavie R., Campos J., Mata S., Urbina M., García M., García A., Apitz R., Lima L. Effect of folic acid combined with fluoxetine in patients with major depression on plasma homcysteine and vitamin B12 and serotonin levels in lymphocytes. Neuroimmunomodulation 2008, 15:145-152.
50. Reynolds E.H., Preece J.M., Path M.C., Bailey J., Coppen A. Folate deficiency in depressive illness. Br J Psychiatry 1970, 117:287-292.
51. Risold P.Y., Swanson L.W. Connections of the rat lateral septal complex. Brain Res Rev 1997, 24:115-195.
52. Stahl S. Novel therapeutics for depression: l-methylfolate as a trimonoamine modulator and antidepressant-augmenting agent. CNS Spectr 2007, 12:739-744.
53. Swanson L.W., Cowan W.M. The connections of the septal region in the rat. J Comp Neurol 1979, 186:621-656.
54. Torras-Garcia M., Costa-Miserachs D., Morgado-Bernal I., Portell-Cortés I. Improvement of shuttle-box performance by anterodorsal medial septal lesions in rats. Behav Brain Res 2003, 141:147-158.
55. Treit D., Fundytus M. Thigmotaxis as a test for anxiolytic activity in rats. Pharmacol Biochem Behav 1988, 31:959-962.
56. Urbina M., Lavie R., Resler G., Campos J., Mata S., Lima L. Síntesis de serotonina y presencia de hidroxilasa de triptófano en linfocitos de pacientes con depresión mayor tratados con fluoxetina y ácido fólico. Arch Venez Farmacol Ter 2008, 27:114-120.